Bill Detail
H.R. 4317
Congress: 119
Title
PBM Reform Act of 2025
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Earl Carter [R-GA-1]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Jun 29, 8:44 PM · synced 10m ago
Introduced
2025-07-10
Data source mode: cache
Bill Engagement
PBM Reform Act of 2025
Sponsor
Rep. Earl Carter [R-GA-1]R
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cosponsors
31D · 39R
Bipartisan
LDA engagement
7 orgs · 9 filings
Top: Pharmaceutical Research and Manufactur…
Introduced
2025-07-10
Lobbyists on the case
7 orgs · 69 lobbyists · 9 filings mention H.R. 4317 (PBM Reform Act of 2025) in LDA disclosures.
Top orgs filing
- Pharmaceutical Research and Manufacturers of America3 filings · 26 lobs
- American Medical Association1 filing · 13 lobs
- America's Health Insurance Plans, Inc. (AHIP)1 filing · 12 lobs
- Cvs Health (and Subsidiaries)1 filing · 8 lobs
- Fierce Government Relations1 filing · 6 lobs
- Roberti Global (F/k/a Roberti White, LLC)1 filing · 3 lobs
Lobbyists on this bill
- Teresa Bill2026 Q1
- Elenora Connors2026 Q1
- Catherine Douglas2026 Q1
- Bart Forsyth2026 Q1
- Jake Freed2026 Q1Pharmaceutical Research and Manufacturers of America · Cong. Affairs Specialist - FDA; Leg. Asst., Leg. Aide/Press Asst., Staff Asst., District Field Re…
- Kelly Goldberg2026 Q1
- Judith Haron2026 Q1
- Lauren Jee2026 Q1
+ 61 more